RAPP - Rapport Therapeutics Inc.
36.56
0.200 0.547%
Share volume: 230,207
Last Updated: 04-24-2026
Pharmaceutical Products/Pharmaceutical Preparations:
-0.11%
PREVIOUS CLOSE
CHG
CHG%
$36.36
0.20
0.01%
View ratios
| Fiscal Date | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 08-08-2024 | 11-07-2024 | 03-11-2025 | 05-08-2025 | 11-06-2025 | 03-10-2026 | |
| Assets | |||||||
| Total Assets | 346.098 M | 331.144 M | 314.933 M | 302.053 M | 535.323 M | 512.431 M | |
| Current Assets | 340.666 M | 325.939 M | 309.802 M | 290.968 M | 520.659 M | 498.561 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 225.975 M | 281.347 M | 248.475 M | 227.778 M | 261.667 M | 437.894 M | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 110.164 M | 39.314 M | 56.805 M | 57.604 M | 251.359 M | 52.645 M | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 3.474 M | 3.409 M | 3.529 M | 3.404 M | 3.116 M | 2.976 M | |
| Other Assets | 1.958 M | 1.796 M | 1.602 M | 7.681 M | 11.548 M | 10.894 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||
| Total Liabilities and shareholders’ equity | 346.098 M | 331.144 M | 314.933 M | 302.053 M | 535.323 M | 512.431 M | |
| Total liabilities | 9.212 M | 8.030 M | 9.506 M | 16.217 M | 23.706 M | 27.778 M | |
| Total current liabilities | 8.095 M | 7.099 M | 8.767 M | 9.383 M | 14.316 M | 19.049 M | |
| Accounts Payable | 1.875 M | 1.323 M | 1.954 M | 2.139 M | 3.235 M | 4.190 M | |
| Other liabilities | 1.117 M | 931.000 K | 739.000 K | 6.834 M | 9.390 M | 8.729 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 1.117 M | 931.000 K | 739.000 K | 6.834 M | 9.390 M | 8.729 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 336.886 M | 323.114 M | 305.427 M | 285.836 M | 511.617 M | 484.653 M | |
| Common stock | 423.297 M | 426.479 M | 429.694 M | 433.739 M | 712.937 M | 719.335 M | |
| Retained earnings | -86.228 M | -103.765 M | -123.745 M | -147.808 M | -201.465 M | -235.228 M |